Overview
- Editors:
-
-
Dirk Lassner
-
Institute of Clinical Chemistry and Pathobiochemistry, University of Leipzig, Leipzig, Germany
-
Barbara Pustowoit
-
Institute of Virology, University of Leipzig, Leipzig, Germany
-
Arndt Rolfs
-
Clinic and Policlinic of Neurology, University of Rostock, Rostock, Germany
Access this book
Other ways to access
Table of contents (13 chapters)
-
Front Matter
Pages I-VIII
-
PCR Quantification and Technical Aspects
-
-
- Tanya Vener, Malin Stark, Jan Albert, Mathias Uhlén, Joakim Lundeberg
Pages 3-10
-
- Meinhard Hahn, Volker Dörsam, Alfred Pingoud
Pages 11-23
-
- David Shire, Pascale Legoux, Adrian J. Minty
Pages 25-35
-
-
- Claus Stefan Vörtler, Klara Birikh
Pages 47-54
-
- Dirk Lassner, Joerg Milde, Matthias Ladusch, Karl Droessler, Harald Remke
Pages 55-63
-
- Volker Uhlmann, Eilhard Mix, Arndt Rolfs
Pages 65-76
-
- Robert L. Burghoff, Jens Beator, Michael A. Harvey
Pages 77-82
-
- Dani Bercovich, Zipi Regev, Tal Ratz, Yoram Plotsky
Pages 83-89
-
PCR Quantification of Infectious Agents
-
-
- Shigetaka Katow, Satoko Arai
Pages 93-100
-
-
- Jens-Uwe Vogel, Bernard Weber
Pages 109-117
-
-
Back Matter
Pages 129-143
About this book
In the ten years since the first publication on PCR (Saiki et al. , 1985), this in vitro method of nucleic acid replication and modification has grown to rival in popularity traditional microbiological, genetical und technical procedures for cloning, sequencing, gene detecting and related procedures. To date the PCR literature has emphasized six main areas of application: genetic mapping, detection of mutations, genetic polymorphism, transcriptional splicing and regulation, molecular virology and quantitative procedures. The overwhelming focus of quantification of DNA or RNA by PCR has been on human microbiology and oncological problems. The exquisite sensitivity of PCR gives this method the ability to detect extremely rare DNAs, mRNAs, mRNAs in small numbers of cells or in small amounts of tissue, and mRNAs expressed in mixed-cell populations. However, the exact and accurate quantification of specific nucleic acids in biological samples is in spite of numerous publications in that field still a general problem: during the peR process, an unknown initial number of target sequences are used as a template from which a large quantity of specific product can be obtained. Although the amount of product formed is easy to determine, it is difficult to deduce the initial copy number of the target molecule because the efficiency of the peR is largely unknown.
Editors and Affiliations
-
Institute of Clinical Chemistry and Pathobiochemistry, University of Leipzig, Leipzig, Germany
Dirk Lassner
-
Institute of Virology, University of Leipzig, Leipzig, Germany
Barbara Pustowoit
-
Clinic and Policlinic of Neurology, University of Rostock, Rostock, Germany
Arndt Rolfs